Overview Dividends

(GEN) Gen Digital - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6687711084

Antivirus, Vpn, Identity, Privacy, Utility

Application Software
Market Cap in USD: 17,203m

IPO / Inception: 1990-03-26
Return 12m vs S&P 500: -12.9%

EPS (Earnings per Share)

EPS CAGR: 9.58%
EPS Trend: 94.9%

Last SUE: 0.67
Qual. Beats: 0

Revenue

Rev. CAGR: 15.88%
Rev. Trend: 90.8%

Last SUE: 0.96
Qual. Beats: 3

Dividends

Dividend Yield	1.81%
Yield on Cost 5y	2.65%
Yield CAGR 5y	-55.28%
Payout Consistency	86.5%
Payout Ratio	20.8%

Risk via 5d forecast
Volatility	26.1%
Value at Risk 5%th	38.6%
Relative Tail Risk	-9.92%

Reward TTM
Sharpe Ratio	0.03
Alpha	-17.31
CAGR/Max DD	0.34

Character TTM
Hurst Exponent	0.541
Beta	0.892
Beta Downside	1.047

Drawdowns 3y
Max DD	34.02%
Mean DD	11.23%
Median DD	10.74%

Description: GEN Gen Digital December 19, 2025

Gen Digital Inc. (NASDAQ: GEN) provides cyber-safety solutions-including security, performance management, identity protection, and online privacy-to consumers, families, and small businesses through the Norton, Avast, LifeLock, MoneyLion, Avira, AVG, and CCleaner brands. The company, formerly NortonLifeLock, rebranded in November 2022 and is headquartered in Tempe, Arizona.

Recent public filings show FY 2023 revenue of roughly **$1.8 billion**, a modest **6 % year-over-year increase** driven primarily by higher subscription renewals in the SMB segment. The firm’s **annual recurring revenue (ARR)** now exceeds **$2.5 billion**, reflecting a shift toward multi-year contracts. A key macro driver is the continued rise in remote-work-induced cyber-risk, which the broader **application-software sector** is seeing as a **CAGR of ~9 %** through 2027 (source: IDC).

Given the competitive landscape and the company’s reliance on brand equity, analysts should monitor **churn rates** (currently estimated at ~12 % for consumer subscriptions) and **integration progress** of recent acquisitions such as MoneyLion, which could materially affect cross-sell opportunities.

For a deeper, data-driven view of GEN’s valuation dynamics, you might explore the analytics platform **ValueRay** to see how its metrics compare across the cyber-security software space.

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (570.0m TTM) > 0 and > 6% of Revenue (6% = 268.4m TTM)

FCFTA 0.08 (>2.0%) and ΔFCFTA -5.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -28.24% (prev -67.46%; Δ 39.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 1.32b > Net Income 570.0m (YES >=105%, WARN >=100%)

Net Debt (8.01b) to EBITDA (2.06b) ratio: 3.88 <= 3.0 (WARN <= 3.5)

Current Ratio 0.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (624.0m) change vs 12m ago 0.32% (target <= -2.0% for YES)

Gross Margin 79.32% (prev 80.38%; Δ -1.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 28.38% (prev 24.91%; Δ 3.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.78 (EBITDA TTM 2.06b / Interest Expense TTM 578.0m) >= 6 (WARN >= 3)

Altman Z'' 0.40

(A) -0.08 = (Total Current Assets 1.29b - Total Current Liabilities 2.55b) / Total Assets 16.05b

(B) 0.01 = Retained Earnings (Balance) 217.0m / Total Assets 16.05b

(D) 0.18 = Book Value of Equity 2.46b / Total Liabilities 13.59b

Total Rating: 0.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 68.92

1. Piotroski 2.0pt

2. FCF Yield 5.16%

3. FCF Margin 29.06%

4. Debt/Equity 3.54

5. Debt/Ebitda 3.88

6. ROIC - WACC (= 1.98)%

7. RoE 24.67%

8. Rev. Trend 90.80%

9. EPS Trend 94.88%

What is the price of GEN shares?

As of December 22, 2025, the stock is trading at USD 27.61 with a total of 21,976,070 shares traded.
Over the past week, the price has changed by -0.22%, over one month by +5.95%, over three months by -4.31% and over the past year by +2.36%.

Is GEN a buy, sell or hold?

Gen Digital has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy GEN.

Strong Buy: 4
Buy: 1
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the GEN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	32.9	19%
Analysts Target Price	32.9	19%
ValueRay Target Price	29.1	5.5%

GEN Fundamental Data Overview December 19, 2025

Market Cap USD = 17.20b (17.20b USD * 1.0 USD.USD)
P/E Trailing = 29.9946
P/E Forward = 9.7276
P/S = 3.846
P/B = 6.8725
P/EG = 0.9035
Beta = 1.112
Revenue TTM = 4.47b USD
EBIT TTM = 1.61b USD
EBITDA TTM = 2.06b USD
Long Term Debt = 8.42b USD (from longTermDebt, last quarter)
Short Term Debt = 280.0m USD (from shortTermDebt, last quarter)
Debt = 8.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.01b USD (from netDebt column, last quarter)
Enterprise Value = 25.21b USD (17.20b + Debt 8.70b - CCE 691.0m)
Interest Coverage Ratio = 2.78 (Ebit TTM 1.61b / Interest Expense TTM 578.0m)
FCF Yield = 5.16% (FCF TTM 1.30b / Enterprise Value 25.21b)
FCF Margin = 29.06% (FCF TTM 1.30b / Revenue TTM 4.47b)
Net Margin = 12.74% (Net Income TTM 570.0m / Revenue TTM 4.47b)
Gross Margin = 79.32% ((Revenue TTM 4.47b - Cost of Revenue TTM 925.0m) / Revenue TTM)
Gross Margin QoQ = 78.20% (prev 78.76%)
Tobins Q-Ratio = 1.57 (Enterprise Value 25.21b / Total Assets 16.05b)
Interest Expense / Debt = 1.68% (Interest Expense 146.0m / Debt 8.70b)
Taxrate = 42.49% (99.0m / 233.0m)
NOPAT = 923.6m (EBIT 1.61b * (1 - 42.49%))
Current Ratio = 0.51 (Total Current Assets 1.29b / Total Current Liabilities 2.55b)
Debt / Equity = 3.54 (Debt 8.70b / totalStockholderEquity, last quarter 2.46b)
Debt / EBITDA = 3.88 (Net Debt 8.01b / EBITDA 2.06b)
Debt / FCF = 6.16 (Net Debt 8.01b / FCF TTM 1.30b)
Total Stockholder Equity = 2.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.55% (Net Income 570.0m / Total Assets 16.05b)
RoE = 24.67% (Net Income TTM 570.0m / Total Stockholder Equity 2.31b)
RoCE = 14.97% (EBIT 1.61b / Capital Employed (Equity 2.31b + L.T.Debt 8.42b))
RoIC = 8.49% (NOPAT 923.6m / Invested Capital 10.89b)
WACC = 6.50% (E(17.20b)/V(25.90b) * Re(9.30%) + D(8.70b)/V(25.90b) * Rd(1.68%) * (1-Tc(0.42)))
Discount Rate = 9.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.64%
[DCF Debug] Terminal Value 74.41% ; FCFE base≈1.63b ; Y1≈1.69b ; Y5≈1.92b
Fair Price DCF = 43.85 (DCF Value 27.04b / Shares Outstanding 616.7m; 5y FCF grow 3.71% → 3.0% )
EPS Correlation: 94.88 | EPS CAGR: 9.58% | SUE: 0.67 | # QB: 0
Revenue Correlation: 90.80 | Revenue CAGR: 15.88% | SUE: 0.96 | # QB: 3
EPS current Year (2026-03-31): EPS=2.54 | Chg30d=+0.006 | Revisions Net=+5 | Growth EPS=+14.4% | Growth Revenue=+25.6%
EPS next Year (2027-03-31): EPS=2.86 | Chg30d=+0.015 | Revisions Net=+2 | Growth EPS=+12.5% | Growth Revenue=+4.7%

Additional Sources for GEN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle